Prognostic Understanding for Older, Medically Infirm, and/or Frail Recipients of Allogeneic Hematopoietic Cell Transplantation in an Ongoing Seamless Phase 2/3 Randomized Interventional Trial (ACE-BMT)Elizabeth T. Loggers, Mohamed L. Sorror, James Fausto et al.|Blood|2024Cited by 0
Prognostic Accuracy of Transplant Clinicians Compared to Recipients of Allogeneic Hematopoietic Cell Transplantation Who Are Older, Medically Infirm, and/or Frail and Enrolled in an Ongoing Seamless Phase 2/3 Randomized Interventional Trial (ACE-BMT)Elizabeth T. Loggers, Mohamed L. Sorror, Reena Jayani et al.|Transplantation and Cellular Therapy|2025Cited by 0